RT Journal Article SR Electronic T1 General practitioners’ awareness of pregnancy: trends and association with hazardous medication use JF British Journal of General Practice JO Br J Gen Pract FD British Journal of General Practice SP BJGP.2022.0193 DO 10.3399/BJGP.2022.0193 A1 Eline Houben A1 Karin M.A. Swart A1 Eric A.P. Steegers A1 Petra J.M. Elders A1 Ron M.C. Herings YR 2022 UL http://bjgp.org/content/early/2022/11/15/BJGP.2022.0193.abstract AB Background: GPs have been shown to be important providers of medical care during pregnancy, however little evidence exists on their awareness of pregnancy when prescribing medication to women. Aim: To assess GPs’ awareness of pregnancy and its association with prescribing medication with potential safety risks. Design and Setting: Population-based study using confirmed pregnancy records linked to GP records from the PHARMO Perinatal Research Network. Method: GPs’ awareness of pregnancy, defined as the presence of a pregnancy confirmation in the GP information system during pregnancy, was assessed from 2004 to 2020. GP prescriptions of medication with potential safety risks were selected during pregnancy and its association with GPs’ awareness of pregnancy was assessed using multivariable logistic regression. Results: A pregnancy confirmation was present in the GP records for 48% of 140,976 selected pregnancies, increasing from 28% in 2004 to 63% in 2020. During 3% of all pregnancies, the GP prescribed high risk medication with teratogenic effects that should have been (temporarily) avoided. Pregnancy was GP-confirmed for only 13% at the first occurrence of such a prescription. Comparative analyses showed that women without a pregnancy confirmation were 59% more likely to be prescribed this high risk medication (OR 95%CI: 1.59 1.49-1.70) compared to those with. Conclusion: Results of this study indicate a potential GP awareness issue at the time medication with potential safety risks is prescribed. Although pregnancy registration by GPs improved over the years, still inadequate use seems to be made of the available information systems for appropriate drug surveillance.